Adriana Olar to Isocitrate Dehydrogenase
This is a "connection" page, showing publications Adriana Olar has written about Isocitrate Dehydrogenase.
Connection Strength
1.470
-
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr; 129(4):585-96.
Score: 0.471
-
Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults. Ann Diagn Pathol. 2012 Jun; 16(3):161-70.
Score: 0.379
-
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathol. 2018 08; 136(2):273-291.
Score: 0.146
-
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO. Acta Neuropathol. 2015 Jun; 129(6):867-73.
Score: 0.120
-
Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol. 2012 Dec; 13(4):417-36.
Score: 0.101
-
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9.
Score: 0.096
-
Anaplastic ganglioglioma-A diagnosis comprising several distinct tumour types. Neuropathol Appl Neurobiol. 2022 12; 48(7):e12847.
Score: 0.050
-
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019 09 06; 21(9):1164-1174.
Score: 0.040
-
DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018 08; 136(2):255-271.
Score: 0.037
-
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
Score: 0.031